POROMS: Prospective, Observational, Real-world Oral Malignant Tumors Study

Sponsor
Beijing Stomatological Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT02395367
Collaborator
Peking University Hospital of Stomatology (Other), Beijing Shijitan Hospital of Capital Medical University (Other), Beijing Friendship Hospital (Other), The First Affiliated Hospital of Zhengzhou University (Other), Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (Other)
3,000
6
120
500
4.2

Study Details

Study Description

Brief Summary

The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in north Chinese population.

Condition or Disease Intervention/Treatment Phase
  • Procedure: resection
  • Radiation: adjuvant radiotherapy
  • Drug: neoadjuvant chemotherapy or adjuvant chemotherapy

Detailed Description

A register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in north Chinese population was absent.

The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in Chinese population. The variables in the study include social informatics, etiology, and psychological and quality of life, coexistence disease, baseline clinicopathological data, postoperative complications, and long-term follow-up results.

By released annual analysis report, the epidemiological features and prognostic factors of oral and maxillofacial malignant tumors in north Chinese population can be identified.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
3000 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
A Prospective, Observational, Real-world Study Based on the Register System of Oral and Maxillofacial Malignant Tumors
Study Start Date :
Mar 1, 2015
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Outcome Measures

Primary Outcome Measures

  1. disease-specific survival [5 years]

    Disease-specific survival was calculated as the time from the first operation to the time of death or last follow-up; patients who died from causes other than oral and maxillofacial cancer were defined as survivors at the time of death.

Secondary Outcome Measures

  1. tumor recurrence [5 years]

    Tumor recurrence was defined as local recurrence postoperatively.

  2. neck recurrence [5 years]

    Neck recurrence was defined as regional recurrence whether was associated with local recurrence and distant metastasis or not.

  3. multiple primary carcinomas [5 years]

    The multiple primary carcinomas include second primary carcinoma and multiple synchronous primary cancers.

  4. distant metastasis [5 years]

  5. postoperative change from Baseline in quality of life score (UW-QOL questionnaire) [1-5 years]

    The comparison between preoperative and postoperative quality of life score using UW-QOL questionnaire.

  6. postoperative change from Baseline in anxiety and depression (Hospital Anxiety and Depression Scale, and Distress Thermometer) [1-5 years]

    The comparison between preoperative and postoperative score of anxiety and depression using "Hospital Anxiety and Depression Scale" and "Distress Thermometer".

  7. postoperative complications [10 days; 42 days; 90 days]

    The postoperative complications were evaluated according to the Clavien-Dindo classification and the Accordion classification.

  8. preoperative comorbidity [1-5 years]

    The preoperative comorbidity was evaluated using Adult Comorbidity Evaluation -27 (ACE-27,Chinese Version).

  9. delay time of cancer diagnosis [0-2 years]

    The delay time of cancer diagnosis was calculated as the time from the chief complaint to the pathological diagnosis.

  10. Radiotherapy relative complications [10 years]

    The complications of postoperative radiotherapy

  11. The correlation among cancer family history, carcinogenesis and prognosis [10 years]

    The carcinogenesis and prognostic role of family history in patients with head and neck malignancies

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • histological diagnosis of oral and maxillofacial malignant tumors

  • no previous treatment

  • a primary tumor without distant metastasis evidence

  • sites: lip, tongue, buccal mucosa, upper and lower gingiva, floor of the mouth, hard palate, oropharynx, salivary gland, upper and lower jaw, and maxillary sinus

Exclusion Criteria:
  • patients decline to participate the study

  • refusal or inability to receive definitive treatment for the disease

  • recurrent tumors

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University Beijing Beijing China 100038
2 Beijing Friendship Hospital, Capital Medical University Beijing Beijing China 100050
3 Beijing Stomatological Hospital, Capital Medical University Beijing Beijing China 100050
4 School of Stomatology, Peking University Beijing Beijing China 100081
5 Department of Oral and Maxillofacial Surgery, First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China 450052
6 Department of Oral and Maxillofacial-Head & Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai China 200011

Sponsors and Collaborators

  • Beijing Stomatological Hospital
  • Peking University Hospital of Stomatology
  • Beijing Shijitan Hospital of Capital Medical University
  • Beijing Friendship Hospital
  • The First Affiliated Hospital of Zhengzhou University
  • Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Investigators

  • Principal Investigator: Zhien Feng, M.D., Ph.D., Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University.
  • Principal Investigator: Dian-can Wang, M.D., Department of Oral and Maxillofacial Surgery, School of Stomatology Peking University.
  • Principal Investigator: Xiaolei Liu, Ph.D., Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University
  • Principal Investigator: Zhen Wang, Ph.D., Beijing Friendship Hospital, Capital Medical Universiy
  • Principal Investigator: Wei Cao, Ph.D., Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
  • Principal Investigator: Qiang Sun, Ph.D., The First Affiliated Hospital of Zhengzhou University
  • Principal Investigator: Xu Wang, Ph.D., Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beijing Stomatological Hospital
ClinicalTrials.gov Identifier:
NCT02395367
Other Study ID Numbers:
  • BeiSH
First Posted:
Mar 23, 2015
Last Update Posted:
Jun 14, 2022
Last Verified:
May 1, 2022
Keywords provided by Beijing Stomatological Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 14, 2022